Company / Free Cash Flow per Share
NOVAVAX INC Free Cash Flow per Share History
FY2016-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.28
FY2022
5-year range
-$1.28 / $3.74
FY2018-FY2022
Trend
-134.2%
vs FY2021
Sector context
#115 of 192
Health Care
What the data says
At $-1.28, NOVAVAX INC's free cash flow per share ranks #115 of 192 in the Health Care sector. Improved from $-3.00 to $-1.28 over the past 2 years.
Based on SEC 10-K filings.
-1.28 in FY2022.
Improved from $-3.00 to $-1.28 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#115 of 192 in Health CareTop 60% of 192This company -$1.28 Sector average $3.32
▼
-138.5% below sector average
Key checks
Key Insights
- In FY2022, free cash flow per share decreased 134.2% year-over-year.
- Ranks #115 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | -$1.28 | -134.2% |
| FY2021 | $3.74 | +224.6% |
| FY2020 | -$3.00 | +61.2% |
| FY2019 | -$7.73 | -802.6% |
| FY2018 | -$0.86 | -61.0% |
| FY2017 | -$0.53 | -93.4% |
| FY2016 | -$0.28 | -28.5% |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026